Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,080.00 | |
50 mg | 10-14 weeks | $ 1,410.00 | |
100 mg | 10-14 weeks | $ 2,130.00 |
Description | CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay). |
Targets&IC50 | CCR1:1.8 nM (in Ca2+ flux assay) |
Molecular Weight | 451.47 |
Formula | C22H18FN5O3S |
CAS No. | 1295298-26-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCR1 antagonist 8 1295298-26-8 Immunology/Inflammation Microbiology/Virology CCR CCR-1 antagonist 8 inhibitor inhibit